Fusion of an EGFR-antagonistic affibody enhances the anti-tumor effect of TRAIL to EGFR positive tumors
EGFR拮抗亲和体的融合增强了TRAIL对EGFR阳性肿瘤的抗肿瘤作用
期刊:International Journal of Pharmaceutics
影响因子:5.3
doi:10.1016/j.ijpharm.2022.121746
Dianlong Jia, Feifei Wang, Yue Lu, Ping Hu, Rui Wang, Guangyong Li, Renmin Liu, Jun Li, Huimin Liu, Qing Fan, Fengjiao Yuan